tradingkey.logo
tradingkey.logo
Search

Biomerica Inc

BMRA
Add to Watchlist
1.750USD
-0.020-1.13%
Close 07/02, 13:00ETQuotes delayed by 15 min
5.30MMarket Cap
LossP/E TTM

Biomerica Inc

1.750
-0.020-1.13%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-1.13%

5 Days

0.00%

1 Month

-18.41%

6 Months

-30.83%

Year to Date

-30.56%

1 Year

-46.48%

Key Figures
1.790Open
1.790High
12.01KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.40%Turnover Ratio
1.800Prev. Close
1.730Low
19.55KTurnover
LossP/E Static
1.60P/B
0.00%Div Yield TTM
-68.12%ROA
4.60052wk High
2.90Volume Ratio
-4.97MNet Profit
3.03MShares
-1.6136EPS TTM
0.30Beta
-94.32%ROE
1.86652wk Low
3.33%Amplitude
-4.46%Gross Margin
5.30MMarket Cap
-4.49Reward/Risk
3.58%Risk Rate

TradingKey Stock Score of Biomerica Inc

Currency: USD Updated: 2026-07-02

Key Insights

Biomerica Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 161 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Biomerica Inc's Score

Industry at a Glance

Industry Ranking
161 / 204
Overall Ranking
485 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Biomerica Inc Highlights

StrengthsRisks
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.31M.
Overvalued
The company’s latest PE is -1.08, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 94.38K shares, decreasing 72.64% quarter-over-quarter.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space

Biomerica Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Biomerica Inc Info

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Ticker SymbolBMRA
CompanyBiomerica Inc
CEOIrani (Zackary S)
Websitehttps://biomerica.com/

FAQs

What is the current price of Biomerica Inc (BMRA)?

The current price of Biomerica Inc (BMRA) is 1.75.

What is the symbol of Biomerica Inc?

The ticker symbol of Biomerica Inc is BMRA.

What is the 52-week high of Biomerica Inc?

The 52-week high of Biomerica Inc is 4.60.

What is the 52-week low of Biomerica Inc?

The 52-week low of Biomerica Inc is 1.87.

What is the market capitalization of Biomerica Inc?

The market capitalization of Biomerica Inc is 5.30M.

What is the Earnings Per Share (EPS TTM) of Biomerica Inc (BMRA)?

The Earnings Per Share (EPS TTM) of Biomerica Inc (BMRA) is -2.16.